Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin with IV and Oral Vinorelbine in Locally Advanced NSCLC
NCT01839032Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- May 2005
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Pierre Fabre Laboratories. Started May 2005; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01839032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839032.